Clinton: SCOTUS Myriad Genetics Decision 'Terrific'
June 14 (Bloomberg) -- Former President Bill Clinton discusses the U.S. Supreme Court's decision in Association for Molecular Pathology v. Myriad Genetics, Inc. with Trish Reagan at the Clinton Global Initiative in Chicago. The ruling, which found human genes cannot be patented, will "generate untold thousands of jobs in this country," he says.
Most Recent Videos
Edgy Design Gives Puma Brand a Boost, Says CEO Gulden
15:46 - Puma SE reported second-quarter profit that topped analysts’ estimates as the German sneaker maker got a lift from Europe’s soccer championships and a focus on the women’s market. Earnings before interest and taxes rose to 12 million euros ($13 million), Puma said in a statement Wednesday, beating analysts’ average expectation of 10.6 million euros. Sales rose 7 percent to 827 million euros, compared with the 820 million-euro consensus. The company fought negative currency-conversion effects by keeping a lid on costs. Chief Executive Officer Bjoern Gulden, three years into a turnaround effort, is balancing sports and style, pushing brash multicolored soccer cleats and a partnership with sprinter Usain Bolt. Gulden joined Bloomberg's Francine Lacqua on "The Pulse."